Ok, anyone think about why there are confidential discussions ongoing with the other agencies in addition to the FDA? Me thinks because discussions are centered around how distribution of LL is to be done amongst all of the countries. Since the USA has not put dollar one into the development of LL there is no reason why distribution should (could) be limited to the USA. Conclusion - trial results are stat sig.